CIPRALEX

This brand name is authorized in Austria, Canada, Croatia, Cyprus, Estonia, Finland, Germany, Israel, Italy, Lithuania, Malta, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CIPRALEX contains one active pharmaceutical ingredient (API):

1	Escitalopram UNII 5U85DBW7LO - ESCITALOPRAM OXALATE
	Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity. The inhibition of 5-HT re-uptake is the only likely mechanism of action explaining the pharmacological and clinical effects of escitalopram.
	Read more about Escitalopram

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CIPRALEX Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
CIPRALEX Oral drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB10	Escitalopram	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02263238, 02263254
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00246296, 00246445, 00681000, 00681017, 01377422, 01547226, 01610255, 01610261, 01610278, 01638549, 01638555, 01638561, 01638584, 01638590, 01708215, 02217459, 02217471, 02217531, 03338171, 03338685, 03417924, 03417930, 03500401, 03770164, 05362392, 05559901, 06572855, 06885620, 06885637, 07000463, 07000486, 07000492, 07005590, 07005609, 07005615, 07073746, 07073752, 07521009, 09294405, 11017328, 11017676, 12470691, 12470768, 12470774, 12900708, 15888652
EE	Ravimiamet	1102521, 1102543, 1102554, 1102598, 1286861, 1286883, 1286894, 1286906, 1286917, 1286939, 1286940, 1287053, 1287064, 1287086, 1287097, 1287109, 1287110, 1287121, 1287132, 1287143, 1774739, 1774740, 1774751, 1774762, 1774773, 1774784, 1774795, 1774807, 1774818, 1774829, 1827671
ES	Centro de información online de medicamentos de la AEMPS	0020132, 65230, 65231, 65233, 65234, 68811
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005790, 005812, 005845, 005867, 005902, 005922, 011314, 092005
GB	Medicines & Healthcare Products Regulatory Agency	138493, 154534, 161484, 175349, 175351, 302676, 33888, 373765, 49426, 73319
HR	Agencija za lijekove i medicinske proizvode	HR-H-405715048
IL	מִשְׂרַד הַבְּרִיאוּת	4592, 6152, 6710
IT	Agenzia del Farmaco	035767250, 035767375, 035767654, 041825023, 045337019, 047407010
LT	Valstybinė vaistų kontrolės tarnyba	1003976, 1003977, 1003978, 1004991, 1024876, 1024877, 1024878, 1024882, 1024883, 1024884, 1025066, 1025068, 1026693, 1026694, 1026695, 1026696, 1026697, 1026698, 1026699, 1026700, 1026701, 1026715, 1026716, 1026717, 1026718, 1026719, 1026720, 1026721, 1026722, 1026723, 1026724, 1035259, 1056080, 1056081, 1056083, 1081003, 1081005, 1088140
MT	Medicines Authority	MA601/00301, MA601/00302, MA601/00304, PI908/02801A
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13298001, W13298002, W13298003, W13298004, W13298005, W13298006, W13298007, W13298008, W13298009, W13298010, W13298011, W13298012, W13298013, W13298014, W13298015, W13298018, W13298019
TR	İlaç ve Tıbbi Cihaz Kurumu	8699795090703, 8699795090710, 8699795091083, 8699795091090, 8699795091106, 8699795091113, 8699795091120, 8699795091137, 8699795091199, 8699795091205
ZA	Health Products Regulatory Authority	36/1.2/0318, 36/1.2/0319, 36/1.2/0320, 36/1.2/0321